Euro Leder Fash (526468)
Asset PlayScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹21.75 |
| Market Cap | ₹9.75 Cr |
| P/E Ratio | 25.5 |
| ROCE | 4.72% |
| ROE | 2.14% |
| Dividend Yield | 0% |
| Profit Growth | 66.67% |
| Debt/Equity | — |
| Sales Growth | -3.28% |
| 52-Week Range | ₹15.06 — ₹26.4 |
| Sector | Consumer Durables |
| Book Value | ₹31.11 |
Strengths
- Trades at a 30% discount to book value: P/B 0.70 against book value of ₹31.11
- Piotroski F-Score of 6/9 indicates reasonably healthy financials for a microcap
- Reported profit growth of 66.67% shows some recent bottom-line improvement
- Small scale and low share price may attract bargain hunters if asset value holds
Concerns
- Very low return on equity of 2.14% and ROCE of 4.72% indicate weak business economics
- Latest quarter net profit is ₹0 Cr on sales of ₹5 Cr, showing no current earnings cushion
- Sales growth is negative at -3.28%, and dividend yield is zero
- P/E of 25.50 is rich given stagnant sales and negligible latest-quarter profit
AI Analysis
At ₹21.75, Euro Leder Fash is a microcap selling at 70% of book value of ₹31.11. In Graham's language, the margin of safety exists on the balance sheet, but the income statement does not excite me. The company earns a meagre ROE of 2.14% and ROCE of 4.72%, telling me this is not a great compounding machine. Sales actually declined 3.28% last year, and the latest quarter's net profit is effectively ₹0 Cr on sales of ₹5 Cr. The reported profit growth of 66.67% sounds nice, but with such a low base and zero latest-quarter earnings, I cannot project that growth forward. The PEG of 0.38 is a trap if the 'G' is not durable. This is a sub-₹10 Cr market cap name in gems and jewellery, where moats are rare, margins are thin, and working capital demands are heavy. On the positive side, a Piotroski score of 6/9 suggests the financial position is not deteriorating, and buying below book provides a tangible asset cushion. But as Buffett, I would rather buy a wonderful business at a fair price than a mediocre business at a bargain. No dividend, no growth, and no clear catalyst make this more of a cigar butt than a compounding opportunity. I would watch whether management can improve returns on equity and stabilise sales. If book value stays intact and a genuine turnaround emerges, today's price could prove cheap. But I need evidence of operational improvement, not just a low P/B multiple.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer